DELPHINUS MEDICAL TECHNOLOGIES, INC.

Profile

Company Names

DELPHINUS MEDICAL TECHNOLOGIES, INC.

Addresses

45525 GRAND RIVER AVENUE, NOVI, MI 48374

46701 COMMERCE CENTER DRIVE, PLYMOUTH, MI 48170

HUDSON-WEBBER CRC ROOM 504, 4100 JOHN R, DETROIT, MI 48201

Phone Numbers

248-522-9513
313-576-8252
248-207-1211

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$117,947,818.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-03-22 
$27,602,177.00 
$27,602,177.00 
$0.00 
Debt 
5
2023-06-20 
$5,000,000.00 
$8,000,000.00 
$3,000,000.00 
Equity 
4
2022-08-30 
$30,406,961.00 
$30,406,961.00 
$0.00 
Equity 
3
2017-04-13 
$8,229,049.00 
$25,000,000.00 
$16,770,951.00 
Equity 
2
2015-08-31 
$39,547,131.00 
$44,999,999.00 
$5,452,868.00 
Equity 
1
2010-05-14 
$7,162,500.00 
$9,550,000.00 
$2,387,500.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ELISE 
 
BERMAN 
EXECUTIVE OFFICER
RACHEL 
 
BREM 
DIRECTOR
FRANCIS 
 
DOBSCHA 
EXECUTIVE OFFICER
NEB 
 
DURIC 
EXECUTIVE OFFICER
NEB 
 
DURIC, PH.D. 
EXECUTIVE OFFICER
MICHAEL 
 
EMERY 
EXECUTIVE OFFICER
MARK 
 
FORCHETTE 
EXECUTIVE OFFICER, DIRECTOR
MARK 
J. 
FORCHETTE 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
C. 
GREENWAY 
EXECUTIVE OFFICER, DIRECTOR
RONALD 
 
HO 
DIRECTOR
ROBERT 
P. 
KELCH 
DIRECTOR
SHAWN 
 
O-BRIEN 
EXECUTIVE OFFICER
W. 
JAMES 
PROWSE 
EXECUTIVE OFFICER, DIRECTOR
HEATHER 
 
RONE 
EXECUTIVE OFFICER
OLIVIER 
 
ROY 
EXECUTIVE OFFICER
CHRIS 
 
SANDERS 
EXECUTIVE OFFICER
DEBRA 
 
SAUNDERS 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-03-22 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-03-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-03-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#